Showing 1 - 4 of 4
The German biotechnology lag illuminates the difficulties of finding appropriate organizational forms of R&D for “embryo” innovations requiring the continued involvement of basic research scientists even after innovation has advanced to the stage of commercial product development. The...
Persistent link: https://www.econbiz.de/10005715317
Persistent link: https://www.econbiz.de/10001418890
Persistent link: https://www.econbiz.de/10008935635
Persistent link: https://www.econbiz.de/10014562558